PASITHEA THERAPEUTICS CORP. Proceeds from (Repayments of) Notes Payable
PASITHEA THERAPEUTICS CORP. (KTTA) reported Proceeds from (Repayments of) Notes Payable of -$392.35 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-24.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfNotesPayable · last filed 2025-03-24
- PASITHEA THERAPEUTICS CORP. proceeds from (repayments of) notes payable for the quarter ending 2023-12-31 was $0.00.
- PASITHEA THERAPEUTICS CORP. proceeds from (repayments of) notes payable for fiscal 2023 was -$392.35K.
| Period end | Proceeds from (Repayments of) Notes Payable 3 month | Proceeds from (Repayments of) Notes Payable 9 month | Proceeds from (Repayments of) Notes Payable 12 month |
|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$392.35K 10-K · filed 2025-03-24 | |
| 2023-09-30 | -$392.35K 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |